Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunity

Infection and Immunity

Volumn 74, Issue 6, 2006, Pages 3607-3617

  Zhang, Jianfeng ^a   Shi, Zhongkai ^a   Kong, Fan Kun ^a   Jex, Edward ^a   Huang, Zhigang ^a   Watt, James M ^a   Van Kampen, Kent R ^a   Tang, De Chu C ^a  

^a Vaxin Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; ANTIGEN; BACTERIAL DNA; TETANUS TOXIN; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BIODEGRADATION; CLOSTRIDIUM TETANI; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GAMMA IRRADIATION; GENE VECTOR; IMMUNE SYSTEM; IMMUNITY; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; VACCINE PRODUCTION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTHRAX; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BASE SEQUENCE; ESCHERICHIA COLI; ESCHERICHIA COLI VACCINES; FEMALE; GAMMA RAYS; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; REPRESSOR PROTEINS; SKIN; T-LYMPHOCYTES; TETANUS; VACCINATION;

EID: 33646943204     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01836-05     Document Type: Article

References (41)

1. Backman, K., and M. Ptashne. 1978. Maximizing gene expression on a plasmid using recombination in vitro. Cell 13:65-71.
2. Blander, J. M., and R. Medzhitov. 2004. Regulation of phagosome maturation by signals from Toll-like receptors. Science 304:1014-1018.
3. Blattner, F. R., G. Plunkett III, C. A. Bloch, N. T. Perna, V. Burland, M. Riley, J. Collado-Vides, J. D. Glasner, C. K. Rode, G. F. Mayhew, J. Gregor, N. W. Davis, H. A. Kirkpatrick, M. A. Goeden, D. J. Rose, B. Mau, and Y. Shao. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1474.
4. Bramson, J., K. Dayball, C. Evelegh, Y. H. Wan, D. Page, and A. Smith, 2003. Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. Gene Ther. 10:251-260.
5. Brandes, M., K. Willimann, and B. Moser, 2005. Professional antigen-presentation function by human gammadelta T Cells. Science 309:264-268.
6. Brest, P., F. Bétis, N. Çuburu, E. Selva, M. Herrant, A. Servin, P. Auberger, and P. Hofman. 2004. Increased rate of apoptosis and diminished phagocytic ability of human neutrophils infected with Afa/Dr diffusely adhering Escherichia coli strains. Infect. Immun. 72:5741-5749.
7. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Biol. Technology 10:888-892.
8. Dieli, F., M. Troye-Blomberg, J. Ivanyi, J. J. Fournie, A. M. Krensky, M. Bonneville, M. A. Peyrat, N. Caccamo, G, Sireci, and A. Salerno. 2001. Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J. Infect. Dis. 184: 1082-1085.
9. Eisenbraun, M. D., D. H. Fuller, and J. R. Haynes. 1993. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12:791-797.
10. Feurle, J., E. Espinosa, S. Eckstein, F. Pont, V. Kunzmann, J. J. Fournie, M. Herderich, and M. Wilhelm. 2002. Escherichia coli produces phosphoantigens activating human gamma delta T cells. J. Biol. Chem. 277:148-154.
11. Glenn, G. M., M. Rao, G. R. Matyas, and C. R. Alving. 1998. Skin immunization made possible by cholera toxin. Nature 391:851.
12. Glenn, G. M., T. Scharton-Kersten, R. Vassell, G. R. Matyas, and C. R. Alving. 1999. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants. Infect. Immun. 67:1100-1106.
13. Glenn, G. M., D. N. Taylor, X. Li, S. Frankel, A. Montemarano, and C. R. Alving. 2000. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat. Med. 6:1403-1406,
14. Hershey, H. V., and M. W. Taylor. 1986. Nucleotide sequence and deduced amino acid sequence of Escherichia coli adenine phosphoribosyltransferase and comparison with other analogous enzymes. Gene 43:287-293.
15. Huang, C. M., K. Foster, T. DeSilva, J. Zhang, Z. Shi, N. Yusuf, K, R. Van Kampen, C. A. Elmets, and D. C. Tang. 2003. Comparative proteomic profiling of murine skin. J. Investig. Dermatol. 121:51-64.
16. Huang, C. M., K. W. Foster, T. S. DeSilva, K. R. Van Kampen, C. A. Elmets, and D. C. Tang. 2004. Identification of Bacillus anthracis proteins associated with germination and early outgrowth by proteomic profiling of anthrax spores. Proteomics 4:2653-2661.
17. Huang, C. M., Z. Shi, T. S. DeSilva, M. Yamamoto, K. R. Van Kampen, C. A. Elmets, and D. C. Tang. 2005. A differential proteome in tumors suppressed by an adenovirus-based skin patch vaccine encoding human carcinoembryonic antigen. Proteomics 5:1013-1023.
18. Huang, Q., D. Liu, P. Majewski, L. C. Schulte, J. M. Korn, R. A. Young, E. S. Lander, and N. Hacohen. 2001. The plasticity of dendritic cell responses to pathogens and their components. Science 294:870-875.
19. Itakura, K., T. Hirose, R. Crea, A. D. Riggs, H. L. Heyneker, F. Bolivar, and H. W. Boyer. 1977. Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 198:1056-1063.
20. Kenney, R. T., J. Yu, M. Guebre-Xabier, S. A. Frech, A. Lambert, B. A. Heller, L. R. Ellingsworth, J. E. Eyles, E. D. Williamson, and G. M. Glenn. 2004. Induction of protective immunity against lethal anthrax challenge with a patch. J. Infect. Dis. 190:774-782.
21. Klimpel, K. R., N. Arora, and S. H. Leppla. 1994. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13:1093-1100.
22. Lees, C. Y., D. J. Briggs, X. Wu, R. D. Davis, S. M. Moore, C. Gordon, Z. Xiang, H. C. Ertl, D. C. Tang, and Z. F. Fu. 2002. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein. Vet. Microbiol. 85:295-303.
23. Leslie, S. B., E. Israeli, B. Lighthart, J. H. Crowe, and L. M. Crowe. 1995. Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying. Appl. Environ. Microbiol. 61:3592-3597.
24. Makoff, A. J., M. D. Oxer, M. A. Romanos, N. F. Fairweather, and S. Ballantine. 1989. Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons. Nucleic Acids Res. 17:10191-10202.
25. Miyamoto-Shinohara, Y., J. Sukenobe, T. Imaizumi, and T. Nakahara. 2006. Survival curves for microbial species stored by freeze-drying. Cryobiology 52:27-32.
26. Molne, L., A. Corthay, R. Holmdahl, and A. Tarkowski. 2003. Role of gamma/delta T cell receptor-expressing lymphocytes in cutaneous infection caused by Staphylococcus aureus. Clin. Exp. Immunol. 132:209-215.
27. Price, B. M., A. L. Liner, S. Park, S. H. Leppla, A. Mateczun, and D. R. Galloway. 2001. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Infect. Immun. 69:4509-4515.
28. Queen, C. 1983. A vector that uses phage signals for efficient synthesis of proteins in Escherichia coli. J. Mol. Appl. Genet. 2:1-10.
29. Shi, Z., M. Zeng, G. Yang, F. Siegel, L. J. Cain, K. R. Van Kampen, C. A. Elmets, and D. C. Tang. 2001. Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines. J. Virol. 75:11474-11482.
30. Smith, H. W. 1978. Is it safe to use Escherichia coli K12 in recombinant DNA experiments. J. Infect. Dis. 137:655-660.
31. Spies, T. 2002. Induction of T cell alertness by bacterial colonization of intestinal epithelium. Proc. Natl. Acad. Sci. USA 99:2584-2586.
32. Swain, S. L., H. Hu, and G. Huston. 1999. Class II-independent generation of CD4 memory T cells from effectors. Science 286:1381-1383.
33. Tang, D. C., M. DeVit, and S. A. Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356:152-154.
34. Tang, D. C., R. S. Jennelle, Z. Shi, R. I. Garver, Jr., D. P. Carbone, F. Loya, C.-H. Chang, and D. T. Curiel. 1997. Overexpression of adenovirus-encoded transgenes from the cytomegalovirus immediate early promoter in irradiated tumor cells. Hum. Gene Ther. 8:2117-2124.
35. Tang, D. C., Z. Shi, and D. T. Curiel. 1997. Vaccination onto bare skin. Nature 388:729-730.
36. Thoma-Uszynski, S., S. Stenger, O. Takeuchi, M. T. Ochoa, M. Engele, P. A. Sieling, P. F. Barnes, M. Rollinghoff, P. L. Bolcskei, M. Wagner, S. Akira, M. V. Norgard, J. T. Belisle, P. J. Godowski, B. R. Bloom, and R. L. Modlin. 2001. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 291:1544-1547.
37. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1748.
38. Van Kampen, K. R., Z. Shi, P. Gao, J. Zhang, K. W. Foster, D. T. Chen, D. Marks, C. A. Elmets, and D. C. Tang. 2005. Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine 23:1029-1036.
39. Welkos, S. L., and A. M. Friedlander. 1988. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microb. Pathog. 5:127-139.
40. Welkos, S. L., and A. M. Friedlander. 1988. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microb. Pathog. 4:53-69.
41. Welkos, S. L., J. R. Lowe, F. Eden-McCutchan, M. Vodkin, S. H. Leppla, and J. J. Schmidt. 1988. Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene 69:287-300.